Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation
- PMID: 32865708
- DOI: 10.1007/s12185-020-02980-0
Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation
Abstract
Germline GATA2 heterozygous mutations were identified as complex immunodeficiency and hematological syndromes characterized by cytopenia (monocytes, B-cells, NK-cells), susceptibility to mycobacterium, fungus, or Epstein-Barr virus (EBV) infection, and myelodysplastic syndrome (MDS)/acute myelogenous leukemia (AML) development. Herein, we report a patient with AML who had a fatal infection after allogeneic hematopoietic stem cell transplantation (HSCT) due to impaired immune reconstitution associated with GATA2 mutation. A 15-year-old man was diagnosed with AML with monosomy 7. His family history was negative for immunodeficiency and hematological disorders. He attained complete remission after HSCT from an HLA-identical sister. Post-HSCT examinations performed 15 months later revealed pancytopenia, especially monocytopenia and the absence of B and NK cells, resulting in the occurrence of donor-type MDS. Twenty-one months after HSCT, he developed central nervous system aspergillosis and finally died of the disease. Two months later (24 months after PBSCT), the donor was diagnosed with persistent EBV infection accompanied by MDS with multilineage dysplasia. Genetic analysis of GATA2 revealed a novel heterozygous mutation (c.1023_1026dupCGCC) in both siblings. GATA2 mutations were highly prevalent among adolescent MDS/AML patients with monosomy 7. Therefore, the screening of GATA2 mutations in relatives is necessary when performing HSCT from a relative donor.
Keywords: Allogeneic hematopoietic stem cell transplantation; Family donor; Germline GATA2 mutation; Poor outcome.
Similar articles
-
Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.Biol Blood Marrow Transplant. 2020 Jun;26(6):1124-1130. doi: 10.1016/j.bbmt.2020.02.015. Epub 2020 Feb 20. Biol Blood Marrow Transplant. 2020. PMID: 32088370 Free PMC article.
-
Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.Int J Hematol. 2023 Nov;118(5):642-646. doi: 10.1007/s12185-023-03603-0. Epub 2023 Apr 21. Int J Hematol. 2023. PMID: 37084069
-
A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.Int J Hematol. 2021 Aug;114(2):286-291. doi: 10.1007/s12185-021-03130-w. Epub 2021 Mar 23. Int J Hematol. 2021. PMID: 33759087
-
Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature.Ann Hematol. 2018 Oct;97(10):1961-1973. doi: 10.1007/s00277-018-3388-4. Epub 2018 Jun 13. Ann Hematol. 2018. PMID: 29947977 Review.
-
Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.Pediatr Transplant. 2016 Nov;20(7):1004-1007. doi: 10.1111/petr.12764. Epub 2016 Jul 15. Pediatr Transplant. 2016. PMID: 27416790 Review.
Cited by
-
Detecting likely germline variants during tumor-based molecular profiling.J Clin Invest. 2025 Aug 1;135(15):e190264. doi: 10.1172/JCI190264. eCollection 2025 Aug 1. J Clin Invest. 2025. PMID: 40759574 Free PMC article. Review.
-
A Systematic Review to Assess the Relationship between Disseminated Cerebral Aspergillosis, Leukemias and Lymphomas, and Their Respective Therapeutics.J Fungi (Basel). 2022 Jul 11;8(7):722. doi: 10.3390/jof8070722. J Fungi (Basel). 2022. PMID: 35887477 Free PMC article. Review.
-
The spectrum of GATA2 deficiency syndrome.Blood. 2023 Mar 30;141(13):1524-1532. doi: 10.1182/blood.2022017764. Blood. 2023. PMID: 36455197 Free PMC article.
-
Aspergillosis of central nervous system in patients with leukemia and stem cell transplantation: a systematic review of case reports.Ann Clin Microbiol Antimicrob. 2021 Jun 15;20(1):44. doi: 10.1186/s12941-021-00452-9. Ann Clin Microbiol Antimicrob. 2021. PMID: 34130699 Free PMC article.
References
-
- Calvo KR, Vinh DC, Maric I, Wang W, Noel P, Stetler-Stevenson M, et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica. 2011;96:1221–5. - DOI
-
- Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, Olivier KN, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115:1519–29. - DOI
-
- Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43:929–31. - DOI
-
- Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, McGovern N, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med. 2011;208:227–34. - DOI
-
- Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43:1012–7. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous